超性心肌病的当代外科管理
Hartzell V Schaff1, Xiang Wei2
1Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.
The Annals of thoracic surgery
|November 1, 2023
概括
隔膜肌切除术有效地通过缓解左心室外流通道 (LVOT) 阻塞来治疗症状性阻塞性多变性心肌病 (HCM). 这种手术方法在精心挑选的患者中改善了呼吸障碍和胸痛等症状.
科学领域:
- 心脏病学 心脏病学
- 心血管外科心血管外科
- 医疗成像医学成像
背景情况:
- 超过一半的症状性多变性心肌病 (HCM) 患者经历左心室外流通道 (LVOT) 阻塞.
- 隔膜缩小疗法,特别是隔膜肌切除术,是缓解阻塞症状的关键治疗方法.
研究的目的:
- 审查目前对隔膜肌切除术在治疗阻塞性HCM中的理解.
- 详细介绍关于隔膜缩小疗法的当代手术方法.
主要方法:
- 综述当前关于多变性心肌病和隔膜肌切除术的文献.
- 讨论诊断成像技术,如多普勒心声学和心脏MRI.
- 分析手术方法及其演变.
主要成果:
- 截面肌切除术可以显著缓解诸如炼性呼吸不良,胸痛和昏等症状.
- 了解高的可变分布和程度对于手术规划至关重要.
- 先进的成像允许精确评估阻塞,心室功能和心心膜形态.
结论:
- 截面肌切除术是选择性阻塞性HCM患者的重要管理途径.
- 现代手术技术,通过先进的成像技术,提供有效的缓解LVOT阻塞.
- 进一步了解HCM病理生理学指南改善了外科手术的结果.
相关概念视频
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy III: Hypertrophic Cardiomyopathy
15
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
15
Cardiomyopathy VII: Pre and Post Operative Nursing Management
15
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
15
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Pericarditis III: Medical Management
13
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
13


